Roche's Tecentriq OK'd in Canada for first-line lung cancer - Seeking Alpha

Roche's Tecentriq OK'd in Canada for first-line lung cancer  Seeking Alpha

Health Canada approves Roche's (RHHBY) Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, for the first-line treatm.



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked